Immune Design Reports Second Quarter 2015 Financial Results
Go back to Immune Design Reports Second Quarter 2015 Financial Results| (NASDAQ: IMDZ) | Delayed: 5.85 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.85 | 52 Week High | $23.55 | |||
| Open | $17.64 | 52 Week Low | $4.50 | |||
| Day High | $5.85 | P/E | N/A | |||
| Day Low | $5.85 | EPS | $0.00 | |||
| Volume | 192,912 | |||||
| Merck & Co. (NYSE: MRK) | Delayed: 141.82 +1.21 (0.86%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $140.61 | 52 Week High | $65.46 | |||
| Open | $140.22 | 52 Week Low | $47.97 | |||
| Day High | $142.11 | P/E | 96.48 | |||
| Day Low | $139.83 | EPS | $1.47 | |||
| Volume | 2,216,305 | |||||



